Halothane: How should it be used in a developing country?;Mode d'utilisation de l'halothane dans un pays en développement

Eastern Mediterranean Health Journal

Volumn 18, Issue 2, 2012, Pages 159-164

  Mahboobi, N ^a   Esmaeili, S ^a   Safari, S ^a   Habibollahi, P ^a   Dabbagh, A ^b   Alavian, S M ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HALOTHANE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG INDUCED DISEASE; DRUG USE; HUMAN; INCIDENCE; QUESTIONNAIRE; TOXIC HEPATITIS;

EID: 84857815732     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2012.18.2.159     Document Type: Article

References (25)

1. Johnstone M. The human cardiovascular response to fluothane anaesthesia. 1956. British Journal of Anaesthesia, 1998, 80:396-40, discussion 395.
2. Whalen FX, Bacon DR, Smith HM. Inhaled anesthetics: an historical overview. Best Practice & Research. Clinical Anaesthesiology, 2005, 19:323-330.
3. Black GW, Clarke RS. Recently introduced anesthetic drugs. International Anesthesiology Clinics, 1971, 9:171-196.
4. Stevens WC. New Halogenated Anesthetics: Enflurane and Isoflurane. California Medicine, 1972, 117:47.
5. Eger EI 2nd. Partition coefficients of I-653 in human blood, saline, and olive oil. Anesthesia and Analgesia, 1987, 66:971-973.
6. Wallin RF et al. Sevoflurane: a new inhalational anesthetic agent. Anesthesia and Analgesia, 1975, 54:758-766.
7. Harper NJ. Inhalational anaesthetics. Anaesthesia and Intensive Care Medicine, 2004, 5:278-282.
8. Voigt MD et al. Halothane hepatitis in a South African population-- frequency and the influence of gender and ethnicity. South African Medical Journal, 1997, 87:882-885.
9. Otedo AE. Halothane induced hepatitis: case report. East African Medical Journal, 2004, 81:538-539.
10. Eghtesadi-Araghi P et al. Halothane hepatitis in Iran: a review of 59 cases. World Journal of Gastroenterology, 2008, 14:5322-5326.
11. Kumar GP, Bhat VJ, Sowdi V. Fulminant hepatic failure following halothane anaesthesia. Journal of Clinical Forensic Medicine, 2005, 12:271-273.
12. What agents are available? Pharmacology, 2000, 11 (http://www.nda.ox.ac.uk/wfsa/html/u11/u1115_02.htm accessed 1 November 2011).
13. Dabbagh A, Rajaei S. Halothane: Is there still any place for using the gas as an anesthetic? Hepatitis Monthly,. 2011, 11(7):511-512.
14. Ray DC, Drummond GB. Halothane hepatitis. British Journal of Anaesthesia, 1991, 67:84-99.
15. Fallahian F. Halothane Induced Hepatitis (CME). Shiraz E Medical Journal, 2009, 10(4):209-220.
16. Perlata R et al. Halothane hepatotoxicity. (http://emedicine.medscape.com/article/166232-overview, accessed 2 November 2011).
17. Dugan CM et al. A mouse model of severe halothane hepatitis based on human risk factors. Journal of Pharmacology and Experimental Therapeutics, 2010, 333:364-372
18. EurasiaHealth Knowledge Network. Health Resources Digest. December 2006. Critical Appraisal Tools (http://www.eurasiahealth.org/attaches/99150/digest_Dec06_eng.pdf, accessed 14 December 2011).
19. Smith I et al. A multicentre comparison of the costs of anaesthesia with sevoflurane or propofol. British Journal of Anaesthesia, 1999, 83:564-570.
20. Lin CY, Wong CS, Wu CT. Cost analysis of three anesthetic regimens under auditory evoked potential monitoring in gynecologic laparoscopic surgery. Acta Anaesthesiologica Taiwanica, 2008. 46(1):53; author reply 53-4.
21. Schuster M et al. A retrospective comparison of costs for regional and general anesthesia techniques. Anesthesia and Analgesia, 2005, 100:786-794.
22. Jackson T, Myles PS. Part II: total episode costs in a randomized, controlled trial of the effectiveness of four anesthetics. Anesthesia and Analgesia, 2000, 91:1170-1175.
23. Martin JL et al. Hepatotoxicity after desflurane anesthesia. Anesthesiology, 1995, 83:1125-1129.
24. Lehmann A et al. Case report: fatal hepatic failure after aortic valve replacement and sevoflurane exposure. Canadian Journal of Anaesthesia, 2007, 54:917-921.
25. Carrigan TW, Straughen WJ. A report of hepatic necrosis and death following isoflurane anesthesia. Anesthesiology, 1987, 67:581-583.